You just read:

FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis

News provided by

Bayer HealthCare Pharmaceuticals

11 Mar, 2010, 09:00 ET